Da Costa R, Riggs L, Solesio M
Biochem Soc Trans. 2023; 51(6):2153-2161.
PMID: 37955101
PMC: 10842919.
DOI: 10.1042/BST20230735.
Sanchis P, Prieto R, Konieczna J, Grases F, Abete I, Salas-Salvado J
Nutrients. 2023; 15(7).
PMID: 37049631
PMC: 10097286.
DOI: 10.3390/nu15071791.
Ralph D, Levine M, Millan J, Uitto J, Li Q
J Bone Miner Res. 2023; 38(4):457-463.
PMID: 36807615
PMC: 10365072.
DOI: 10.1002/jbmr.4791.
Pujol A, Sanchis P, Grases F, Masmiquel L
Antioxidants (Basel). 2023; 12(1).
PMID: 36671007
PMC: 9855079.
DOI: 10.3390/antiox12010146.
Scala R, Maqoud F, Antonacci M, Dibenedetto J, Perrone M, Scilimati A
Front Pharmacol. 2022; 13:837534.
PMID: 35370739
PMC: 8965324.
DOI: 10.3389/fphar.2022.837534.
Prevalence of metabolic abnormalities in patients with urolithiasis in Kinshasa, Democratic Republic of Congo.
Diangienda P, Moningo D, Sumaili E, Mayindu A, Punga-Maole A, Haymann J
Pan Afr Med J. 2021; 40:75.
PMID: 34804342
PMC: 8590275.
DOI: 10.11604/pamj.2021.40.75.28349.
Understanding the Protective Effect of Phytate in Bone Decalcification Related-Diseases.
Sanchis P, Lopez-Gonzalez A, Costa-Bauza A, Busquets-Cortes C, Riutord P, Calvo P
Nutrients. 2021; 13(8).
PMID: 34445019
PMC: 8400850.
DOI: 10.3390/nu13082859.
Bisphosphonates in dentistry: Historical perspectives, adverse effects, and novel applications.
Sedghizadeh P, Sun S, Jones A, Sodagar E, Cherian P, Chen C
Bone. 2021; 147:115933.
PMID: 33757899
PMC: 8076070.
DOI: 10.1016/j.bone.2021.115933.
DOTA-ZOL: A Promising Tool in Diagnosis and Palliative Therapy of Bone Metastasis-Challenges and Critical Points in Implementation into Clinical Routine.
Meisenheimer M, Kurpig S, Essler M, Eppard E
Molecules. 2020; 25(13).
PMID: 32629930
PMC: 7412164.
DOI: 10.3390/molecules25132988.
Bisphosphonate-Based Molecules as Potential New Antiparasitic Drugs.
Branco Santos J, de Melo J, Maheshwari S, de Medeiros W, de Freitas Oliveira J, Moreno C
Molecules. 2020; 25(11).
PMID: 32503272
PMC: 7321420.
DOI: 10.3390/molecules25112602.
The rs1256328 (ALPL) and rs12654812 (RGS14) Polymorphisms are Associated with Susceptibility to Calcium Nephrolithiasis in a Taiwanese population.
Chen W, Chou W, Chu H, Huang C, Liu X, Chang W
Sci Rep. 2019; 9(1):17296.
PMID: 31754202
PMC: 6872875.
DOI: 10.1038/s41598-019-53261-8.
Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.
Bowden S, Foster B
Adv Exp Med Biol. 2019; 1148:279-322.
PMID: 31482504
DOI: 10.1007/978-981-13-7709-9_13.
Trauma-Induced Nanohydroxyapatite Deposition in Skeletal Muscle is Sufficient to Drive Heterotopic Ossification.
Moore-Lotridge S, Li Q, Gibson B, Martin J, Hawley G, Arnold T
Calcif Tissue Int. 2018; 104(4):411-425.
PMID: 30515544
PMC: 6437294.
DOI: 10.1007/s00223-018-0502-5.
Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy.
Bowden S, Foster B
Drug Des Devel Ther. 2018; 12:3147-3161.
PMID: 30288020
PMC: 6161731.
DOI: 10.2147/DDDT.S154922.
On-off-on luminescent pyrophosphate probe based on the use of Mn-doped ZnS quantum dots and using Eu(III) as a mediator.
Pang J, Lu Y, Gao X, Song P, Yang F, Liu Y
Mikrochim Acta. 2018; 185(10):480.
PMID: 30259119
DOI: 10.1007/s00604-018-3003-3.
Plasma PPi Deficiency Is the Major, but Not the Exclusive, Cause of Ectopic Mineralization in an Abcc6 Mouse Model of PXE.
Zhao J, Kingman J, Sundberg J, Uitto J, Li Q
J Invest Dermatol. 2017; 137(11):2336-2343.
PMID: 28652107
PMC: 7069658.
DOI: 10.1016/j.jid.2017.06.006.
Pyrophosphate Supplementation Prevents Chronic and Acute Calcification in ABCC6-Deficient Mice.
Pomozi V, Brampton C, van de Wetering K, Zoll J, Calio B, Pham K
Am J Pathol. 2017; 187(6):1258-1272.
PMID: 28416300
PMC: 5455066.
DOI: 10.1016/j.ajpath.2017.02.009.
Phytic acid as alternative setting retarder enhanced biological performance of dicalcium phosphate cement in vitro.
Meininger S, Blum C, Schamel M, Barralet J, Ignatius A, Gbureck U
Sci Rep. 2017; 7(1):558.
PMID: 28373697
PMC: 5429644.
DOI: 10.1038/s41598-017-00731-6.
Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.
Robertson W
Urolithiasis. 2016; 45(1):43-56.
PMID: 27900407
DOI: 10.1007/s00240-016-0953-y.
An Evaluative History of Bisphosphonate Drugs: Dual Physiologic Effects of Pyrophosphate as Inspiration for a Novel Pharmaceutical Class.
Hinshaw W, DeLong A
J Osteoporos. 2016; 2016:1426279.
PMID: 27800209
PMC: 5069370.
DOI: 10.1155/2016/1426279.
